Author

Mingyang Shan 1

1 Eli Lilly and Company,Indianapolis,United States

ABSENCE OF BOWEL URGENCY IS ASSOCIATED WITH IMPROVEMENTS IN CLINICAL OUTCOMES IN PATIENTS WITH ULCERATIVE COLITIS RECEIVING MIRIKIZUMAB

Marla C. Dubinsky, Remo Panaccione, James D Lewis, Bruce E. Sands, Toshifumi Hibi, Scott D. Lee, April Naegeli, Mingyang Shan, Linden Green, Nathan Morris, Vipin Arora, Alison Potts Bleakman, Ruth Belin, Simon Travis

ABSENCE OF BOWEL URGENCY IS ASSOCIATED WITH SIGNIFICANTLY IMPROVED INFLAMMATORY BOWEL DISEASE RELATED QUALITY OF LIFE IN A PHASE 2 TRIAL OF MIRIKIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS

Marla C. Dubinsky, Scott D. Lee, Remo Panaccione, Maria T. Abreu, Severine Vermeire, Trevor Lissoos, Nathan Morris, Vipin Arora, Mingyang Shan, April Naegeli, Bruce E. Sands

BIOMARKERS AND BOWEL URGENCY IN RESPONSE TO MIRIKIZUMAB FOR ULCERATIVE COLITIS

Marla C. Dubinsky, April Naegeli, Mingyang Shan, Sylvie Bradesi, Jochen Schmitz, Catherine Milch, Cem Kayhan, Simon Travis

CHANGE IN URGENCY AMONG CROHN’S DISEASE PATIENTS: ANALYSES FROM THE SPARC IBD

Mingyang Shan, Xian Zhou, Theresa Hunter, April Naegeli, James D. Lewis

CHARACTERISTICS OF ULCERATIVE COLITIS PATIENTS BY URGENCY OF DEFECATION AT ENROLLMENT IN THE CORRONA INFLAMMATORY BOWEL DISEASE REGISTRY

Douglas C. Wolf, April Naegeli, Mingyang Shan, Theresa Hunter Gibble, Angelina Sontag, Page Moore, Rachel Mackey, Margaux Crabtree, Raymond Cross

EFFECT OF MIRIKIZUMAB ON BOWEL URGENCY CLINICALLY MEANINGFUL IMPROVEMENT AND REMISSION: RESULTS FROM THE PHASE 3 LUCENT INDUCTION AND MAINTENANCE STUDIES

Simon Travis, Toshifumi Hibi, Tadakazu Hisamatsu, Deborah Fisher, Mingyang Shan, Theresa Hunter Gibble, David T. Rubin

EFFICACY OF MIRIKIZUMAB IN RESOLVING ACTIVE HISTOLOGIC INFLAMMATION IN ULCERATIVE COLITIS IN LUCENT-1 INDUCTION AND LUCENT-2 MAINTENANCE TRIALS

Fernando Magro, Rish Pai, Taku Kobayashi, Vipul Jairath, Florian Rieder, Isabel Redondo, Trevor Lissoos, Nathan Morris, Mingyang Shan, Laurent Peyrin-Biroulet

MIRIKIZUMAB IMPROVES PATIENT ASSESSMENT OF DISEASE SEVERITY AND CHANGE IN DISEASE ACTIVITY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE

Paul F. Pollock, Theresa Hunter, Mingyang Shan, Lai Shan Chan, Deanilee Deckard, David T. Rubin

MIRIKIZUMAB REDUCES ABDOMINAL PAIN IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE

Edward V. Loftus, Paul Pollack, Theresa Hunter, Mingyang Shan, Deanilee Deckard, Raymond Cross, Lai Shan Chan

MIRIKIZUMAB THERAPY IS ASSOCIATED WITH IMPROVED FATIGUE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE

Miguel Regueiro, Mingyang Shan, Paul Pollack, Lai Shan Chan, Pieter Hindryckx, Theresa Hunter Gibble, Monika Fischer, David T. Rubin, Deanilee Deckard

Item 1 - 10 / 12
1
2